Company Loon Energy Corporation Toronto S.E.
Equities
LNE.H
CA5435123057
Biotechnology & Medical Research
Business Summary
Sales per Business
CAD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Ketamine and Cannabis Referrals
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -25.74% |
Sales per region
CAD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -25.74% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 116,888,491 | 111,948,491 ( 95.77 %) | 0 | 95.77 % |
Company contact information
![address Loon Energy Corporation(LNE.H)](https://cdn.zonebourse.com/static/address/49479050.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+19.44% | 125B | |
+20.01% | 114B | |
+23.09% | 26.73B | |
-23.72% | 19.43B | |
-17.66% | 16.22B | |
-19.87% | 15.33B | |
+55.81% | 14.2B | |
+8.76% | 14.42B | |
-48.79% | 14.33B |